首页> 中文期刊> 《中国医院用药评价与分析》 >α-硫辛酸联合甲钴胺治疗化疗药引起周围神经病变的疗效观察

α-硫辛酸联合甲钴胺治疗化疗药引起周围神经病变的疗效观察

         

摘要

目的:观察硫辛酸联合甲钴胺治疗化疗药所致周围神经病变的疗效。方法:将126例恶性肿瘤化疗后周围神经病变患者随机分为治疗组和对照组,每组63例。治疗组给予α-硫辛酸600 mg静脉滴注、1日1次,甲钴胺500μg,静脉注射、1日1次;对照组单用甲钴胺500μg,静脉注射、1日1次,疗程均为2周。比较2组患者治疗前后临床疗效。结果:治疗组患者总有效率为80.95%(51/63),对照组为47.62%(30/63),治疗组优于对照组,差异有统计学意义(P<0.05)。结论:α-硫辛酸联合甲钴胺治疗化疗药引起周围神经病变安全、有效。%OBJECTIVE:To evaluate the clinical efficacy of α-lipoic acid plus mecobalamin for peripheral neuropathy induced by chemotherapy.METHODS:One hundred and tweenty six patients with chemotherapy-induced peripheral neuropathy were randomly divided into two groups ( of 63 cases each) to be treated with eitherα-lipoic acid (600 mg) q.d by intravenous infusion plus mecobalamin (500 μg) q.d by intravenous injection ( treatment groups) or with mecobalamin (500μg) q.d by intravenous infusion ( control group) for 2 weeks, the clinical efficacy between the two groups were compared.RESULTS: The response rate in the treatment group was better than in the control gorup [ 80.95%( 51/63 ) vs.47.62%( 30/63 ) , P <0.05 ] . CONCLUSIONS: α-Lipoic acid combined with mecobalamin are safe and effective in the treatment of peripheral neuropathy induced by chemotherapy.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号